We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-11.88%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$96.1B
AUM Growth
-$15.5B
Cap. Flow
+$483M
Cap. Flow %
0.5%
Top 10 Hldgs %
15.04%
Holding
4,137
New
391
Increased
1,950
Reduced
1,291
Closed
279

Sector Composition

Rank Sector Weight
1 Financials 11.03%
2 Technology 10.74%
3 Healthcare 9.35%
4 Industrials 6.72%
5 Consumer Discretionary 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCP
3601
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
$134K ﹤0.01%
128,900
+6,800
+6% +$9.54K
BLDP
3602
Ballard Power Systems
BLDP
$805M
$133K ﹤0.01%
55,724
+6,794
+14% +$21.4K
STML
3603
DELISTED
Stemline Therapeutics, Inc.
STML
$133K ﹤0.01%
+14,041
New +$182K
HAPN
3604
PUT
Happen Inc
HAPN
$2.21B
$132K ﹤0.01%
+10,000
New +$165K
PBPB
3605
DELISTED
Potbelly
PBPB
$130K ﹤0.01%
16,133
+6,115
+61% +$65.6K
GPX
3606
DELISTED
GP Strategies Corp.
GPX
$130K ﹤0.01%
+10,287
New +$147K
ARQL
3607
DELISTED
Arqule Inc
ARQL
$130K ﹤0.01%
+46,944
New +$179K
INTT icon
3608
inTEST
INTT
$155M
$129K ﹤0.01%
21,001
-2
-0% -$14
GERN icon
3609
Geron
GERN
$828M
$121K ﹤0.01%
120,101
+12,471
+12% +$18.9K
VRA icon
3610
Vera Bradley
VRA
$97M
$121K ﹤0.01%
14,165
+2,866
+25% +$33.7K
VYGR icon
3611
Voyager Therapeutics
VYGR
$183M
$121K ﹤0.01%
+13,002
New +$167K
ERII icon
3612
Energy Recovery
ERII
$446M
$120K ﹤0.01%
17,848
+4,011
+29% +$31.6K
DSKE
3613
DELISTED
Daseke, Inc. Common Stock
DSKE
$120K ﹤0.01%
32,595
+4,534
+16% +$24.3K
CURO
3614
DELISTED
CURO Group Holdings Corp.
CURO
$119K ﹤0.01%
12,594
-6,681
-35% -$109K
VNTR
3615
DELISTED
Venator Materials PLC
VNTR
$119K ﹤0.01%
28,289
-6,618
-19% -$42.7K
AUPH icon
3616
Aurinia Pharmaceuticals
AUPH
$1.91B
$118K ﹤0.01%
17,215
-1,812
-10% -$10.4K
VNRX icon
3617
VolitionRx Ltd
VNRX
$8.65M
$118K ﹤0.01%
3,250
URA icon
3618
Global X Uranium ETF
URA
$5.42B
$117K ﹤0.01%
10,000
GOGO icon
3619
Gogo Inc
GOGO
$565M
$116K ﹤0.01%
38,735
+7,200
+23% +$36K
NPTN
3620
DELISTED
NEOPHOTONICS CORP
NPTN
$116K ﹤0.01%
+17,899
New +$137K
FBM
3621
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$115K ﹤0.01%
13,886
-596
-4% -$5.91K
CCXI
3622
DELISTED
ChemoCentryx, Inc.
CCXI
$114K ﹤0.01%
+10,418
New +$110K
AGEN
3623
Agenus
AGEN
$312M
$113K ﹤0.01%
2,436
+509
+26% +$21.2K
ONDK
3624
DELISTED
On Deck Capital, Inc.
ONDK
$112K ﹤0.01%
18,905
+648
+4% +$4.61K
BNED icon
3625
Barnes & Noble Education
BNED
$431M
$109K ﹤0.01%
272
+50
+23% +$27.8K

Similar funds

Credit Suisse's Q4 2018 Portfolio in Review

As of Q4 2018, Credit Suisse held 4,137 positions worth $96.1B, down 14% from $112B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse's Q4 2018 filing shows 391 new, 1,950 increased, 1,291 reduced and 279 closed positions. Its largest new stake was Linde: 1,955,783 shares worth $305M. The largest sale was UnitedHealth, an estimated $1.57B.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

  • Credit Suisse's largest Q4 2018 buy was Linde: 1,955,783 shares worth $305M.
  • Credit Suisse added most to VanEck Gold Miners ETF in Q4 2018, an estimated $385M increase.
  • Credit Suisse's biggest Q4 2018 reduction was UnitedHealth, cutting an estimated $1.57B.
  • Credit Suisse fully exited Grifois in Q4 2018, selling an estimated $190M.
  • Credit Suisse's ten largest holdings make up 15% of its $96.1B portfolio in Q4 2018.
  • Credit Suisse opened 391 new positions and closed 279 in Q4 2018.
  • Credit Suisse's portfolio value fell 14% quarter-over-quarter to $96.1B.

Based on Credit Suisse's 13F filing for Q4 2018, filed 13 Feb 2019.